GNVR on OTC

Genvor Inc

Genvor Inc is an American agricultural production-crops company based in Henderson.1 Its shares trade on OTC under the symbol GNVR.1

Price unavailable

Last updated Oct 20, 2026.

Overview

-$5.6MNet income, fiscal 20252

Compare with another stock.

  • TickerGNVR on OTC1
  • IndustryAgricultural Production-Crops1
  • HeadquartersHenderson, Nevada1
  • Incorporated inNV3
  • Business address1550 W Horizon Ridge Pkwy, Ste R #3040, Henderson, Nv 890123
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

72% reduction in fungal growth and 98% reduction in aflatoxin contamination in USDA trials.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Revenue567$0 in 2021
02019: $0$020192020: $0$020202021: $0$02021
Net income568-$3.4M in 2021+57225% since 2019
-$4.0M-$3.0M-$2.0M-$1.0M02019: -$6.0K-$6.0K20192020: -$4.9K-$4.9K2020−19%2021: -$3.4M-$3.4M2021+70527%

Every line of the income statement as filed: the last 2 fiscal years, latest first.2

Period ending2025-09-302024-09-30
Research and development expenses$455.9K$240.3K
Advertising and marketing expenses$4.5K$84.2K
Professional fees$320.4K$1.1M
Compensation and related benefits$5.5M$1.3M
Other general and administrative expenses$131.1K$69.8K
Total Operating Expenses$6.4M$2.8M
LOSS FROM OPERATIONS-$6.4M-$2.8M
Interest expense-$59.8K-$17.7K
Net gain on settlement of accounts payable$13.6K
Gain on extinguishment of notes payable$867.0K$5.8K
Penalties-$90.0K
Other expense-$44
Total Other Expense$820.8K-$101.9K
LOSS BEFORE INCOME TAXES-$5.6M-$2.9M
NET LOSS-$5.6M-$2.9M
Earnings Per Share, Diluted-$0.22-$0.15
Weighted Average Number of Shares Outstanding, Diluted25.7M shares19.9M shares

Compare Genvor Inc with another company

What it owns

What Genvor Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$13.9K2 Sep 30, 2024$15.7K11 Sep 30, 2023−11.6%

Properties, in its own words

Genvor, Inc. operates a research and development laboratory located in Woodland, California. The facility is part of the life-science innovation space operated in partnership with AgStart and is made available to the Company through a lease arrangement awarded under a Bayer-supported program. The current lease term extends through July 2026.

The Woodland laboratory consists of a fully equipped wet-lab environment suitable for early-stage biological research. The space includes standard benchtop laboratory infrastructure and provides access to shared advanced instrumentation typical for molecular, biochemical, and microbiological assay development. These capabilities support the Company’s work in validating and characterizing sequenced peptides intended for use in crop protection applications. Available equipment and shared resources include, but are not limited to, analytical instrumentation, incubation and culture facilities, microscopy, purification systems, and other tools required for routine assay execution and screening workflows.

The rest of Item 2

The laboratory is staffed by one full-time Ph.D.-level scientist who oversees the Company’s research operations, assay development, and experimental validation activities conducted at the site.

The Company does not own any real property. Other than the Woodland, California laboratory, the Company’s headquarters is a virtual facility with an address in Henderson, Nevada enabling the Company to operate with minimal overhead to support its current staff. The Company believes its existing facilities are adequate for its current operational needs.

Item 2 of the 10-K filed Dec 10, 2025.4

Leadership

Who has led Genvor Inc, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Judith Selene Miller2023
  2. Chad Lee Pawlak Sr.2024–now

Chief financial officer

  1. Donald A. Kalkofen2026–now
2025
Board members and other officers (7)

Former names

  • Allure Worldwide, Inc.Nov 22, 2019 to Jun 15, 20223

Timeline

  1. Jun 22, 20268-K Entered a material agreement; Unregistered sale of shares19
  2. May 21, 20268-K Executive or director change; Other events20
  3. May 11, 20268-K Unregistered sale of shares; Bylaws or fiscal year changed21
  4. Apr 22, 20268-K Entered a material agreement22
  5. Sep 4, 20258-K Regulation FD disclosure23
  6. Nov 13, 20248-K Executive or director change24
  7. Oct 22, 20248-K Executive or director change25
  8. Jun 3, 20248-K Executive or director change26
  9. Mar 21, 20248-K Change of auditor27
  10. Mar 11, 2024New chief executive Chad Lee Pawlak Sr. becomes CEO12
  11. Jan 23, 20248-K Entered a material agreement; Executive or director change28
  12. Jan 18, 20248-K Earlier financial statements no longer reliable29
  13. Jan 16, 20248-K Earlier financial statements no longer reliable30
  14. Sep 13, 2023New chief executive Judith Selene Miller becomes CEO13

Filings

80 filings to the SEC since October 2021: 8 annual reports, 20 quarterly reports, 18 major events, 18 insider forms, 2 private raises, 14 other. The latest 20:

  1. Aug 14, 202610-Q QUARTERLY REPORT EDGAR
  2. Jul 31, 2026DEF 14C DEFINITIVE INFORMATION STATEMENT EDGAR
  3. Jul 20, 2026PRE 14C PRELIMINARY INFORMATION STATEMENT EDGAR
  4. Jun 22, 20268-K CURRENT REPORT EDGAR
  5. May 26, 20263 EDGAR
  6. May 21, 20268-K EDGAR
  7. May 13, 202610-Q EDGAR
  8. May 11, 20268-K EDGAR
  9. Apr 22, 20268-K EDGAR
  10. Apr 16, 20264 EDGAR
  11. Apr 14, 20264 EDGAR
  12. Mar 13, 202610-Q/A EDGAR
  13. Feb 12, 202610-Q EDGAR
  14. Jan 9, 20264 EDGAR
  15. Dec 10, 202510-K EDGAR
  16. Dec 5, 2025D EDGAR
  17. Dec 5, 20254 EDGAR
  18. Dec 5, 20253 EDGAR
  19. Oct 9, 20254 EDGAR
  20. Sep 9, 202510-K/A EDGAR

The 80 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Dec 5, 2025Filed a private offering of equity Form D: $7 million offered in all Form D
  2. Apr 8, 2025Raised $425,000 in a private offering of equity Form D: $2.5 million offered in all Form D

SEC filer profile

How Genvor Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGenvor Inc1
  • CIK0001792941
  • Employer ID (EIN)83-20547464
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inNevada4
  • Fiscal year endsSeptember 301
  • Industry code (SIC)0100 Agricultural Production-Crops1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address1550 W Horizon Ridge Pkwy, Ste R #3040, Henderson, NV 890121
  • Phone715.903.64731
  • Shares outstanding36,410,120 as of Aug 14, 202610
  • Public float$0 as of Mar 28, 20252
  • AuditorNovogradac & Company LLP, Plantation, Florida PCAOB ID 474; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceNov 22, 20191
  • Filings104 in all: 10-Q (20), 8-K (19), 4 (12), 10-K (6), S-1/A (6), UPLOAD (6), 10-Q/A (5), 3 (5)1
    All 22 form types

    NT 10-Q (4), 10-K/A (3), 8-K/A (2), CORRESP (2), D (2), EFFECT (2), NT 10-K (2), POS AM (2), 4/A (1), 424B3 (1), 8-A12G (1), DEF 14C (1), PRE 14C (1), S-1 (1)

  • Latest filingsAnnual report (10-K) Dec 10, 2025
    Quarterly report (10-Q) Aug 14, 2026
    Latest 8-K (8-K) Jun 22, 2026

Risk factors and legal proceedings

Legal proceedings

Except as set forth below, as of the date of this Annual Report, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Except as set forth below, management is not aware of any other material pending legal proceedings against us or to which our property is subject.

On February 7, 2024, the Company filed suit against Justin Kimbrough and Prosperity Consultants, LLC, in the 14th Judicial District Court for Dallas County, Texas (case no. DC-24-02022), alleging fraud, conversion, unjust enrichment and other causes of action. The Company and Mr. Kimbrough have settled the claims in dispute, which required Mr. Kimbrough to return a portion of his shares of common stock to the Company totaling 331,250. On October 22, 2025, these shares were returned to the Company and were cancelled.

On April 12, 2024, the Company filed suit against Richard Saied, in the 192nd Judicial District Court for Dallas County, Texas (case no. DC-24-05442), alleging fraud, conversion, unjust enrichment and other causes of action arising from the defendant’s improper receipt of shares of Company common stock under an agreement which required the defendant to provide services to the Company and which services the defendant ultimately never provided. The Company sought monetary damages and for a constructive trust to be imposed on defendant’s shares of Company common stock and for them to be returned to the Company. On October 29, 2025, the court entered judgment in the Company’s favor, with the Company awarded reasonable and necessary attorney fees, and Mr. Saied was ordered to return the contested shares back to the Company.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30